Loading...
XKRX192820
Market cap1.18bUSD
Dec 24, Last price  
151,700.00KRW
1D
0.00%
1Q
16.51%
Jan 2017
26.95%
IPO
96.50%
Name

Cosmax Inc

Chart & Performance

D1W1MN
XKRX:192820 chart
P/E
30.12
P/S
0.97
EPS
5,036.07
Div Yield, %
0.00%
Shrs. gr., 5y
2.10%
Rev. gr., 5y
7.13%
Revenues
1.78t
+11.08%
336,230,290,990533,342,717,780756,963,565,000883,950,013,5701,259,716,816,0601,330,652,928,9701,382,880,688,5201,591,487,621,5001,600,125,770,1901,777,494,448,320
Net income
57.14b
P
16,605,447,82021,243,854,22034,781,930,68018,855,174,65032,621,456,32018,319,679,110-29,053,381,42034,336,481,890-16,446,826,86057,137,182,680
CFO
231.02b
+125.32%
1,169,690,940-6,503,440,45023,468,728,140-6,616,556,840-54,592,032,65074,567,223,71041,459,691,390100,045,547,950102,531,468,480231,020,761,950
Dividend
Dec 27, 2023500 KRW/sh
Earnings
Mar 05, 2025

Profile

Cosmax, Inc. researches, develops, produces, and sells cosmetic, health function food, and pharmaceutical products in Korea and internationally. The company offers skincare, color cosmetics, and hair care products, as well as mask sheets and eye patches. It also develops and manufactures medical supplies and devices; raw materials for cosmetic products; and functional containers and filling packaging products for cosmetics. The company was formerly known as Miroto Korea and changed its name to Cosmax, Inc. in 1994. Cosmax, Inc. was founded in 1992 and is headquartered in Hwaseong, South Korea.
URL
https://www.cosmax.com/
IPO date
Apr 07, 2014
Employees
Domiciled in
KR
Incorporated in
KR

Valuation

Title
KRW in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2023‑122022‑122021‑122020‑122019‑122018‑122017‑122016‑122015‑122014‑12
Income
Revenues
1,777,494,448
11.08%
1,600,125,770
0.54%
1,591,487,622
15.08%
Cost of revenue
1,565,471,444
1,538,154,270
1,448,838,012
Unusual Expense (Income)
NOPBT
212,023,004
61,971,500
142,649,609
NOPBT Margin
11.93%
3.87%
8.96%
Operating Taxes
46,420,850
22,616,508
43,933,855
Tax Rate
21.89%
36.50%
30.80%
NOPAT
165,602,154
39,354,993
98,715,754
Net income
57,137,183
-447.41%
(16,446,827)
-147.90%
34,336,482
-218.18%
Dividends
(6,264,361)
Dividend yield
0.75%
Proceeds from repurchase of equity
(114,800,866)
3,058
132,162,456
BB yield
8.01%
0.00%
-14.11%
Debt
Debt current
453,747,974
516,985,096
448,433,467
Long-term debt
196,975,656
137,670,156
146,434,851
Deferred revenue
43,964,127
Other long-term liabilities
181,413,405
49,347,216
370
Net debt
275,456,633
430,466,801
457,113,800
Cash flow
Cash from operating activities
231,020,762
102,531,468
100,045,548
CAPEX
(86,283,324)
(84,364,779)
(42,108,128)
Cash from investing activities
(104,497,982)
(31,251,949)
(143,689,207)
Cash from financing activities
(39,233,386)
3,471,944
32,504,709
FCF
227,872,040
27,886,096
49,494,053
Balance
Cash
286,391,879
181,374,448
184,355,393
Long term investments
88,875,118
42,814,003
(46,600,875)
Excess cash
286,392,275
144,182,162
58,180,137
Stockholders' equity
301,574,657
186,362,624
187,482,577
Invested Capital
850,618,756
941,747,060
978,877,478
ROIC
18.48%
4.10%
10.75%
ROCE
18.65%
5.71%
13.75%
EV
Common stock shares outstanding
11,346
11,346
10,719
Price
126,400.00
70.58%
74,100.00
-15.22%
87,400.00
-10.60%
Market cap
1,434,091,677
70.58%
840,713,554
-10.26%
936,824,256
-6.27%
EV
1,705,592,803
1,134,301,620
1,298,012,115
EBITDA
271,456,655
120,780,097
194,451,214
EV/EBITDA
6.28
9.39
6.68
Interest
32,114,913
20,969,716
17,507,105
Interest/NOPBT
15.15%
33.84%
12.27%